Amphion Innovations plc

Proposes Re-registration under Isle of Man Companies Act 2006 (as amended)

London and New York, 20 June 2014 –Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, today today gives notice that an Extraordinary General Meeting of Amphion Innovations plc will be held at the offices of Amphion Innovations US, Inc., 330 Madison Avenue, 6th Floor, New York, NY 10017, USA on 7 August 2014 at 11.00 a.m. ET, or so soon thereafter as the Company’s annual general meeting convened for the same date and place has concluded at which the following resolution will be proposed as a special resolution:

Special Resolution

That the Company:

Complete details are contained in the circular which has been sent to shareholders and which is available on the Company’s website. 

For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008

Panmure Gordon Limited
Freddy Crossley / Fred Walsh / (Corporate Finance)
Adam Pollock / Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500

About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: